Green C., McGinley J., Sande C., Capone S., Makvandi-Nejad S., Vitelli A., Silva-Reyes L., Bibi S., Otasowie C., Sheerin D., Thompson A., Dold C., Klenerman P., Barnes E., Dorrell L., Rollier C., Pollard A., O'Connor D.

Cohorts of healthy younger adults (18-50yrs) and healthy older adults (60-75yrs) were immunized intramuscularly or intranasally with an adenovirus-vectored RSV vaccine (PanAd3-RSV) as a prime dose and boosted with PanAd3-RSV or a poxvirus-vectored vaccine (MVA-RSV) encoding the same insert. Whole blood gene expression was measured at baseline, 3- and 7-days post vaccination. Intramuscular prime vaccination with PanAd3-RSV induced differential expression of 643 genes (DEGs, FDR < 0.05). Intranasal prime vaccination with PanAd3-RSV did not induce any differentially expressed genes (DEGs) in blood samples at 3 days post vaccination. Intranasally primed participants showed greater numbers of DEGS on boosting than intramuscularly primed participants. The most highly enriched biological processes related to DEGs after both prime and boost vaccination were type-1 interferon related pathways, lymphocytic and humoral immune responses.

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.

Green C., McGinley J., Sande C., Capone S., Makvandi-Nejad S., Vitelli A., Silva-Reyes L., Bibi S., Otasowie C., Sheerin D., Thompson A., Dold C., Klenerman P., Barnes E., Dorrell L., Rollier C., Pollard A., O'Connor D.

DOI

Type

Journal

Publication Date

Volume

Pages

Keywords